ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
2
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
2
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Urokinase for Injection Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-4E9798
Home | Market Reports | Health| Pharmacy
Global Urokinase for Injection Market Insights and Forecast to 2028
BUY CHAPTERS

Global Urokinase for Injection Market Insights, Forecast to 2030

Code: QYRE-Auto-4E9798
Report
December 2024
Pages:73
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
NDPharm
Wanhua Biochem
Jiangxi Haoran Bio-Pharma
Jiangsu Aidea Pharmaceutical

Urokinase for Injection Market

Urokinase, also known as urokinase-type plasminogen activator (uPA), is a serine protease present in humans and Others animals. 
The global Urokinase for Injection market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Urokinase for Injection is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Urokinase for Injection is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Urokinase for Injection is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key manufacturers of Urokinase for Injection include NDPharm, Wanhua Biochem, Jiangxi Haoran Bio-Pharma and Jiangsu Aidea Pharmaceutical, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Report Covers:
This report presents an overview of global market for Urokinase for Injection, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Urokinase for Injection, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Urokinase for Injection, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Urokinase for Injection sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Urokinase for Injection market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Urokinase for Injection sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Urokinase for Injection Market Report

Report Metric Details
Report Name Urokinase for Injection Market
Segment by Type
Segment by Application
  • Hospital
  • Clinic
  • Others
Segment by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Jiangxi Haoran Bio-Pharma, Jiangsu Aidea Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Sales (consumption), revenue of Urokinase for Injection in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 3: Detailed analysis of Urokinase for Injection manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Urokinase for Injection sales, revenue, price, gross margin, and recent development, etc.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Urokinase for Injection Market report?

Ans: The main players in the Urokinase for Injection Market are Jiangxi Haoran Bio-Pharma, Jiangsu Aidea Pharmaceutical

What are the Application segmentation covered in the Urokinase for Injection Market report?

Ans: The Applications covered in the Urokinase for Injection Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Urokinase for Injection Market report?

Ans: The Types covered in the Urokinase for Injection Market report are Urokinase Powder, Urokinase Solution

Recommended Reports

Thrombolytic & Coagulation

Injection Drug Markets

Biologics & APIs

1 Study Coverage
1.1 Urokinase for Injection Product Introduction
1.2 Market by Type
1.2.1 Global Urokinase for Injection Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Urokinase Powder
1.2.3 Urokinase Solution
1.3 Market by Application
1.3.1 Global Urokinase for Injection Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Urokinase for Injection Sales Estimates and Forecasts 2019-2030
2.2 Global Urokinase for Injection Revenue by Region
2.2.1 Global Urokinase for Injection Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Urokinase for Injection Revenue by Region (2019-2024)
2.2.3 Global Urokinase for Injection Revenue by Region (2025-2030)
2.2.4 Global Urokinase for Injection Revenue Market Share by Region (2019-2030)
2.3 Global Urokinase for Injection Sales Estimates and Forecasts 2019-2030
2.4 Global Urokinase for Injection Sales by Region
2.4.1 Global Urokinase for Injection Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Urokinase for Injection Sales by Region (2019-2024)
2.4.3 Global Urokinase for Injection Sales by Region (2025-2030)
2.4.4 Global Urokinase for Injection Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Urokinase for Injection Sales by Manufacturers
3.1.1 Global Urokinase for Injection Sales by Manufacturers (2019-2024)
3.1.2 Global Urokinase for Injection Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Urokinase for Injection in 2023
3.2 Global Urokinase for Injection Revenue by Manufacturers
3.2.1 Global Urokinase for Injection Revenue by Manufacturers (2019-2024)
3.2.2 Global Urokinase for Injection Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Urokinase for Injection Revenue in 2023
3.3 Global Key Players of Urokinase for Injection, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Urokinase for Injection Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Urokinase for Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Urokinase for Injection, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Urokinase for Injection, Product Offered and Application
3.8 Global Key Manufacturers of Urokinase for Injection, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Urokinase for Injection Sales by Type
4.1.1 Global Urokinase for Injection Historical Sales by Type (2019-2024)
4.1.2 Global Urokinase for Injection Forecasted Sales by Type (2025-2030)
4.1.3 Global Urokinase for Injection Sales Market Share by Type (2019-2030)
4.2 Global Urokinase for Injection Revenue by Type
4.2.1 Global Urokinase for Injection Historical Revenue by Type (2019-2024)
4.2.2 Global Urokinase for Injection Forecasted Revenue by Type (2025-2030)
4.2.3 Global Urokinase for Injection Revenue Market Share by Type (2019-2030)
4.3 Global Urokinase for Injection Price by Type
4.3.1 Global Urokinase for Injection Price by Type (2019-2024)
4.3.2 Global Urokinase for Injection Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Urokinase for Injection Sales by Application
5.1.1 Global Urokinase for Injection Historical Sales by Application (2019-2024)
5.1.2 Global Urokinase for Injection Forecasted Sales by Application (2025-2030)
5.1.3 Global Urokinase for Injection Sales Market Share by Application (2019-2030)
5.2 Global Urokinase for Injection Revenue by Application
5.2.1 Global Urokinase for Injection Historical Revenue by Application (2019-2024)
5.2.2 Global Urokinase for Injection Forecasted Revenue by Application (2025-2030)
5.2.3 Global Urokinase for Injection Revenue Market Share by Application (2019-2030)
5.3 Global Urokinase for Injection Price by Application
5.3.1 Global Urokinase for Injection Price by Application (2019-2024)
5.3.2 Global Urokinase for Injection Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Urokinase for Injection Market Size by Type
6.1.1 US & Canada Urokinase for Injection Sales by Type (2019-2030)
6.1.2 US & Canada Urokinase for Injection Revenue by Type (2019-2030)
6.2 US & Canada Urokinase for Injection Market Size by Application
6.2.1 US & Canada Urokinase for Injection Sales by Application (2019-2030)
6.2.2 US & Canada Urokinase for Injection Revenue by Application (2019-2030)
6.3 US & Canada Urokinase for Injection Market Size by Country
6.3.1 US & Canada Urokinase for Injection Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Urokinase for Injection Sales by Country (2019-2030)
6.3.3 US & Canada Urokinase for Injection Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Urokinase for Injection Market Size by Type
7.1.1 Europe Urokinase for Injection Sales by Type (2019-2030)
7.1.2 Europe Urokinase for Injection Revenue by Type (2019-2030)
7.2 Europe Urokinase for Injection Market Size by Application
7.2.1 Europe Urokinase for Injection Sales by Application (2019-2030)
7.2.2 Europe Urokinase for Injection Revenue by Application (2019-2030)
7.3 Europe Urokinase for Injection Market Size by Country
7.3.1 Europe Urokinase for Injection Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Urokinase for Injection Sales by Country (2019-2030)
7.3.3 Europe Urokinase for Injection Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Urokinase for Injection Market Size
8.1.1 China Urokinase for Injection Sales (2019-2030)
8.1.2 China Urokinase for Injection Revenue (2019-2030)
8.2 China Urokinase for Injection Market Size by Application
8.2.1 China Urokinase for Injection Sales by Application (2019-2030)
8.2.2 China Urokinase for Injection Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Urokinase for Injection Market Size by Type
9.1.1 Asia Urokinase for Injection Sales by Type (2019-2030)
9.1.2 Asia Urokinase for Injection Revenue by Type (2019-2030)
9.2 Asia Urokinase for Injection Market Size by Application
9.2.1 Asia Urokinase for Injection Sales by Application (2019-2030)
9.2.2 Asia Urokinase for Injection Revenue by Application (2019-2030)
9.3 Asia Urokinase for Injection Sales by Region
9.3.1 Asia Urokinase for Injection Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Urokinase for Injection Revenue by Region (2019-2030)
9.3.3 Asia Urokinase for Injection Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Urokinase for Injection Market Size by Type
10.1.1 Middle East, Africa and Latin America Urokinase for Injection Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Urokinase for Injection Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Urokinase for Injection Market Size by Application
10.2.1 Middle East, Africa and Latin America Urokinase for Injection Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Urokinase for Injection Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Urokinase for Injection Sales by Country
10.3.1 Middle East, Africa and Latin America Urokinase for Injection Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Urokinase for Injection Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Urokinase for Injection Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 NDPharm
11.1.1 NDPharm Company Information
11.1.2 NDPharm Overview
11.1.3 NDPharm Urokinase for Injection Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 NDPharm Urokinase for Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 NDPharm Recent Developments
11.2 Wanhua Biochem
11.2.1 Wanhua Biochem Company Information
11.2.2 Wanhua Biochem Overview
11.2.3 Wanhua Biochem Urokinase for Injection Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Wanhua Biochem Urokinase for Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Wanhua Biochem Recent Developments
11.3 Jiangxi Haoran Bio-Pharma
11.3.1 Jiangxi Haoran Bio-Pharma Company Information
11.3.2 Jiangxi Haoran Bio-Pharma Overview
11.3.3 Jiangxi Haoran Bio-Pharma Urokinase for Injection Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Jiangxi Haoran Bio-Pharma Urokinase for Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Jiangxi Haoran Bio-Pharma Recent Developments
11.4 Jiangsu Aidea Pharmaceutical
11.4.1 Jiangsu Aidea Pharmaceutical Company Information
11.4.2 Jiangsu Aidea Pharmaceutical Overview
11.4.3 Jiangsu Aidea Pharmaceutical Urokinase for Injection Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Jiangsu Aidea Pharmaceutical Urokinase for Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Jiangsu Aidea Pharmaceutical Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Urokinase for Injection Industry Chain Analysis
12.2 Urokinase for Injection Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Urokinase for Injection Production Mode & Process
12.4 Urokinase for Injection Sales and Marketing
12.4.1 Urokinase for Injection Sales Channels
12.4.2 Urokinase for Injection Distributors
12.5 Urokinase for Injection Customers
13 Market Dynamics
13.1 Urokinase for Injection Industry Trends
13.2 Urokinase for Injection Market Drivers
13.3 Urokinase for Injection Market Challenges
13.4 Urokinase for Injection Market Restraints
14 Key Findings in The Global Urokinase for Injection Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
FEATURED COMPANIES
NDPharm
Wanhua Biochem
Jiangxi Haoran Bio-Pharma
Jiangsu Aidea Pharmaceutical
List of Tables
    Table 1. Global Urokinase for Injection Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Table 2. Major Manufacturers of Urokinase Powder
    Table 3. Major Manufacturers of Urokinase Solution
    Table 4. Global Urokinase for Injection Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Table 5. Global Urokinase for Injection Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 6. Global Urokinase for Injection Revenue by Region (2019-2024) & (US$ Million)
    Table 7. Global Urokinase for Injection Revenue by Region (2025-2030) & (US$ Million)
    Table 8. Global Urokinase for Injection Revenue Market Share by Region (2019-2024)
    Table 9. Global Urokinase for Injection Revenue Market Share by Region (2025-2030)
    Table 10. Global Urokinase for Injection Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 11. Global Urokinase for Injection Sales by Region (2019-2024) & (Kg)
    Table 12. Global Urokinase for Injection Sales by Region (2025-2030) & (Kg)
    Table 13. Global Urokinase for Injection Sales Market Share by Region (2019-2024)
    Table 14. Global Urokinase for Injection Sales Market Share by Region (2025-2030)
    Table 15. Global Urokinase for Injection Sales by Manufacturers (2019-2024) & (Kg)
    Table 16. Global Urokinase for Injection Sales Share by Manufacturers (2019-2024)
    Table 17. Global Urokinase for Injection Revenue by Manufacturers (2019-2024) & (US$ Million)
    Table 18. Global Urokinase for Injection Revenue Share by Manufacturers (2019-2024)
    Table 19. Global Key Players of Urokinase for Injection, Industry Ranking, 2022 VS 2023 VS 2024
    Table 20. Urokinase for Injection Price by Manufacturers 2019-2024 (USD/Kg)
    Table 21. Global Urokinase for Injection Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 22. Global Urokinase for Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Urokinase for Injection as of 2023)
    Table 23. Global Key Manufacturers of Urokinase for Injection, Manufacturing Base Distribution and Headquarters
    Table 24. Global Key Manufacturers of Urokinase for Injection, Product Offered and Application
    Table 25. Global Key Manufacturers of Urokinase for Injection, Date of Enter into This Industry
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Urokinase for Injection Sales by Type (2019-2024) & (Kg)
    Table 28. Global Urokinase for Injection Sales by Type (2025-2030) & (Kg)
    Table 29. Global Urokinase for Injection Sales Share by Type (2019-2024)
    Table 30. Global Urokinase for Injection Sales Share by Type (2025-2030)
    Table 31. Global Urokinase for Injection Revenue by Type (2019-2024) & (US$ Million)
    Table 32. Global Urokinase for Injection Revenue by Type (2025-2030) & (US$ Million)
    Table 33. Global Urokinase for Injection Revenue Share by Type (2019-2024)
    Table 34. Global Urokinase for Injection Revenue Share by Type (2025-2030)
    Table 35. Urokinase for Injection Price by Type (2019-2024) & (USD/Kg)
    Table 36. Global Urokinase for Injection Price Forecast by Type (2025-2030) & (USD/Kg)
    Table 37. Global Urokinase for Injection Sales by Application (2019-2024) & (Kg)
    Table 38. Global Urokinase for Injection Sales by Application (2025-2030) & (Kg)
    Table 39. Global Urokinase for Injection Sales Share by Application (2019-2024)
    Table 40. Global Urokinase for Injection Sales Share by Application (2025-2030)
    Table 41. Global Urokinase for Injection Revenue by Application (2019-2024) & (US$ Million)
    Table 42. Global Urokinase for Injection Revenue by Application (2025-2030) & (US$ Million)
    Table 43. Global Urokinase for Injection Revenue Share by Application (2019-2024)
    Table 44. Global Urokinase for Injection Revenue Share by Application (2025-2030)
    Table 45. Urokinase for Injection Price by Application (2019-2024) & (USD/Kg)
    Table 46. Global Urokinase for Injection Price Forecast by Application (2025-2030) & (USD/Kg)
    Table 47. US & Canada Urokinase for Injection Sales by Type (2019-2024) & (Kg)
    Table 48. US & Canada Urokinase for Injection Sales by Type (2025-2030) & (Kg)
    Table 49. US & Canada Urokinase for Injection Revenue by Type (2019-2024) & (US$ Million)
    Table 50. US & Canada Urokinase for Injection Revenue by Type (2025-2030) & (US$ Million)
    Table 51. US & Canada Urokinase for Injection Sales by Application (2019-2024) & (Kg)
    Table 52. US & Canada Urokinase for Injection Sales by Application (2025-2030) & (Kg)
    Table 53. US & Canada Urokinase for Injection Revenue by Application (2019-2024) & (US$ Million)
    Table 54. US & Canada Urokinase for Injection Revenue by Application (2025-2030) & (US$ Million)
    Table 55. US & Canada Urokinase for Injection Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 56. US & Canada Urokinase for Injection Revenue by Country (2019-2024) & (US$ Million)
    Table 57. US & Canada Urokinase for Injection Revenue by Country (2025-2030) & (US$ Million)
    Table 58. US & Canada Urokinase for Injection Sales by Country (2019-2024) & (Kg)
    Table 59. US & Canada Urokinase for Injection Sales by Country (2025-2030) & (Kg)
    Table 60. Europe Urokinase for Injection Sales by Type (2019-2024) & (Kg)
    Table 61. Europe Urokinase for Injection Sales by Type (2025-2030) & (Kg)
    Table 62. Europe Urokinase for Injection Revenue by Type (2019-2024) & (US$ Million)
    Table 63. Europe Urokinase for Injection Revenue by Type (2025-2030) & (US$ Million)
    Table 64. Europe Urokinase for Injection Sales by Application (2019-2024) & (Kg)
    Table 65. Europe Urokinase for Injection Sales by Application (2025-2030) & (Kg)
    Table 66. Europe Urokinase for Injection Revenue by Application (2019-2024) & (US$ Million)
    Table 67. Europe Urokinase for Injection Revenue by Application (2025-2030) & (US$ Million)
    Table 68. Europe Urokinase for Injection Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 69. Europe Urokinase for Injection Revenue by Country (2019-2024) & (US$ Million)
    Table 70. Europe Urokinase for Injection Revenue by Country (2025-2030) & (US$ Million)
    Table 71. Europe Urokinase for Injection Sales by Country (2019-2024) & (Kg)
    Table 72. Europe Urokinase for Injection Sales by Country (2025-2030) & (Kg)
    Table 73. China Urokinase for Injection Sales by Type (2019-2024) & (Kg)
    Table 74. China Urokinase for Injection Sales by Type (2025-2030) & (Kg)
    Table 75. China Urokinase for Injection Revenue by Type (2019-2024) & (US$ Million)
    Table 76. China Urokinase for Injection Revenue by Type (2025-2030) & (US$ Million)
    Table 77. China Urokinase for Injection Sales by Application (2019-2024) & (Kg)
    Table 78. China Urokinase for Injection Sales by Application (2025-2030) & (Kg)
    Table 79. China Urokinase for Injection Revenue by Application (2019-2024) & (US$ Million)
    Table 80. China Urokinase for Injection Revenue by Application (2025-2030) & (US$ Million)
    Table 81. Asia Urokinase for Injection Sales by Type (2019-2024) & (Kg)
    Table 82. Asia Urokinase for Injection Sales by Type (2025-2030) & (Kg)
    Table 83. Asia Urokinase for Injection Revenue by Type (2019-2024) & (US$ Million)
    Table 84. Asia Urokinase for Injection Revenue by Type (2025-2030) & (US$ Million)
    Table 85. Asia Urokinase for Injection Sales by Application (2019-2024) & (Kg)
    Table 86. Asia Urokinase for Injection Sales by Application (2025-2030) & (Kg)
    Table 87. Asia Urokinase for Injection Revenue by Application (2019-2024) & (US$ Million)
    Table 88. Asia Urokinase for Injection Revenue by Application (2025-2030) & (US$ Million)
    Table 89. Asia Urokinase for Injection Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 90. Asia Urokinase for Injection Revenue by Region (2019-2024) & (US$ Million)
    Table 91. Asia Urokinase for Injection Revenue by Region (2025-2030) & (US$ Million)
    Table 92. Asia Urokinase for Injection Sales by Region (2019-2024) & (Kg)
    Table 93. Asia Urokinase for Injection Sales by Region (2025-2030) & (Kg)
    Table 94. Middle East, Africa and Latin America Urokinase for Injection Sales by Type (2019-2024) & (Kg)
    Table 95. Middle East, Africa and Latin America Urokinase for Injection Sales by Type (2025-2030) & (Kg)
    Table 96. Middle East, Africa and Latin America Urokinase for Injection Revenue by Type (2019-2024) & (US$ Million)
    Table 97. Middle East, Africa and Latin America Urokinase for Injection Revenue by Type (2025-2030) & (US$ Million)
    Table 98. Middle East, Africa and Latin America Urokinase for Injection Sales by Application (2019-2024) & (Kg)
    Table 99. Middle East, Africa and Latin America Urokinase for Injection Sales by Application (2025-2030) & (Kg)
    Table 100. Middle East, Africa and Latin America Urokinase for Injection Revenue by Application (2019-2024) & (US$ Million)
    Table 101. Middle East, Africa and Latin America Urokinase for Injection Revenue by Application (2025-2030) & (US$ Million)
    Table 102. Middle East, Africa and Latin America Urokinase for Injection Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 103. Middle East, Africa and Latin America Urokinase for Injection Revenue by Country (2019-2024) & (US$ Million)
    Table 104. Middle East, Africa and Latin America Urokinase for Injection Revenue by Country (2025-2030) & (US$ Million)
    Table 105. Middle East, Africa and Latin America Urokinase for Injection Sales by Country (2019-2024) & (Kg)
    Table 106. Middle East, Africa and Latin America Urokinase for Injection Sales by Country (2025-2030) & (Kg)
    Table 107. NDPharm Company Information
    Table 108. NDPharm Description and Major Businesses
    Table 109. NDPharm Urokinase for Injection Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
    Table 110. NDPharm Urokinase for Injection Product Model Numbers, Pictures, Descriptions and Specifications
    Table 111. NDPharm Recent Developments
    Table 112. Wanhua Biochem Company Information
    Table 113. Wanhua Biochem Description and Major Businesses
    Table 114. Wanhua Biochem Urokinase for Injection Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
    Table 115. Wanhua Biochem Urokinase for Injection Product Model Numbers, Pictures, Descriptions and Specifications
    Table 116. Wanhua Biochem Recent Developments
    Table 117. Jiangxi Haoran Bio-Pharma Company Information
    Table 118. Jiangxi Haoran Bio-Pharma Description and Major Businesses
    Table 119. Jiangxi Haoran Bio-Pharma Urokinase for Injection Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
    Table 120. Jiangxi Haoran Bio-Pharma Urokinase for Injection Product Model Numbers, Pictures, Descriptions and Specifications
    Table 121. Jiangxi Haoran Bio-Pharma Recent Developments
    Table 122. Jiangsu Aidea Pharmaceutical Company Information
    Table 123. Jiangsu Aidea Pharmaceutical Description and Major Businesses
    Table 124. Jiangsu Aidea Pharmaceutical Urokinase for Injection Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
    Table 125. Jiangsu Aidea Pharmaceutical Urokinase for Injection Product Model Numbers, Pictures, Descriptions and Specifications
    Table 126. Jiangsu Aidea Pharmaceutical Recent Developments
    Table 127. Key Raw Materials Lists
    Table 128. Raw Materials Key Suppliers Lists
    Table 129. Urokinase for Injection Distributors List
    Table 130. Urokinase for Injection Customers List
    Table 131. Urokinase for Injection Market Trends
    Table 132. Urokinase for Injection Market Drivers
    Table 133. Urokinase for Injection Market Challenges
    Table 134. Urokinase for Injection Market Restraints
    Table 135. Research Programs/Design for This Report
    Table 136. Key Data Information from Secondary Sources
    Table 137. Key Data Information from Primary Sources
List of Figures
    Figure 1. Urokinase for Injection Product Picture
    Figure 2. Global Urokinase for Injection Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Urokinase for Injection Market Share by Type in 2023 & 2030
    Figure 4. Urokinase Powder Product Picture
    Figure 5. Urokinase Solution Product Picture
    Figure 6. Global Urokinase for Injection Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 7. Global Urokinase for Injection Market Share by Application in 2023 & 2030
    Figure 8. Hospital
    Figure 9. Clinic
    Figure 10. Others
    Figure 11. Urokinase for Injection Report Years Considered
    Figure 12. Global Urokinase for Injection Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 13. Global Urokinase for Injection Revenue 2019-2030 (US$ Million)
    Figure 14. Global Urokinase for Injection Revenue Market Share by Region in Percentage: 2023 Versus 2030
    Figure 15. Global Urokinase for Injection Revenue Market Share by Region (2019-2030)
    Figure 16. Global Urokinase for Injection Sales 2019-2030 ((Kg)
    Figure 17. Global Urokinase for Injection Sales Market Share by Region (2019-2030)
    Figure 18. US & Canada Urokinase for Injection Sales YoY (2019-2030) & (Kg)
    Figure 19. US & Canada Urokinase for Injection Revenue YoY (2019-2030) & (US$ Million)
    Figure 20. Europe Urokinase for Injection Sales YoY (2019-2030) & (Kg)
    Figure 21. Europe Urokinase for Injection Revenue YoY (2019-2030) & (US$ Million)
    Figure 22. China Urokinase for Injection Sales YoY (2019-2030) & (Kg)
    Figure 23. China Urokinase for Injection Revenue YoY (2019-2030) & (US$ Million)
    Figure 24. Asia (excluding China) Urokinase for Injection Sales YoY (2019-2030) & (Kg)
    Figure 25. Asia (excluding China) Urokinase for Injection Revenue YoY (2019-2030) & (US$ Million)
    Figure 26. Middle East, Africa and Latin America Urokinase for Injection Sales YoY (2019-2030) & (Kg)
    Figure 27. Middle East, Africa and Latin America Urokinase for Injection Revenue YoY (2019-2030) & (US$ Million)
    Figure 28. The Urokinase for Injection Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
    Figure 29. The Top 5 and 10 Largest Manufacturers of Urokinase for Injection in the World: Market Share by Urokinase for Injection Revenue in 2023
    Figure 30. Global Urokinase for Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 31. Global Urokinase for Injection Sales Market Share by Type (2019-2030)
    Figure 32. Global Urokinase for Injection Revenue Market Share by Type (2019-2030)
    Figure 33. Global Urokinase for Injection Sales Market Share by Application (2019-2030)
    Figure 34. Global Urokinase for Injection Revenue Market Share by Application (2019-2030)
    Figure 35. US & Canada Urokinase for Injection Sales Market Share by Type (2019-2030)
    Figure 36. US & Canada Urokinase for Injection Revenue Market Share by Type (2019-2030)
    Figure 37. US & Canada Urokinase for Injection Sales Market Share by Application (2019-2030)
    Figure 38. US & Canada Urokinase for Injection Revenue Market Share by Application (2019-2030)
    Figure 39. US & Canada Urokinase for Injection Revenue Share by Country (2019-2030)
    Figure 40. US & Canada Urokinase for Injection Sales Share by Country (2019-2030)
    Figure 41. U.S. Urokinase for Injection Revenue (2019-2030) & (US$ Million)
    Figure 42. Canada Urokinase for Injection Revenue (2019-2030) & (US$ Million)
    Figure 43. Europe Urokinase for Injection Sales Market Share by Type (2019-2030)
    Figure 44. Europe Urokinase for Injection Revenue Market Share by Type (2019-2030)
    Figure 45. Europe Urokinase for Injection Sales Market Share by Application (2019-2030)
    Figure 46. Europe Urokinase for Injection Revenue Market Share by Application (2019-2030)
    Figure 47. Europe Urokinase for Injection Revenue Share by Country (2019-2030)
    Figure 48. Europe Urokinase for Injection Sales Share by Country (2019-2030)
    Figure 49. Germany Urokinase for Injection Revenue (2019-2030) & (US$ Million)
    Figure 50. France Urokinase for Injection Revenue (2019-2030) & (US$ Million)
    Figure 51. U.K. Urokinase for Injection Revenue (2019-2030) & (US$ Million)
    Figure 52. Italy Urokinase for Injection Revenue (2019-2030) & (US$ Million)
    Figure 53. Russia Urokinase for Injection Revenue (2019-2030) & (US$ Million)
    Figure 54. China Urokinase for Injection Sales Market Share by Type (2019-2030)
    Figure 55. China Urokinase for Injection Revenue Market Share by Type (2019-2030)
    Figure 56. China Urokinase for Injection Sales Market Share by Application (2019-2030)
    Figure 57. China Urokinase for Injection Revenue Market Share by Application (2019-2030)
    Figure 58. Asia Urokinase for Injection Sales Market Share by Type (2019-2030)
    Figure 59. Asia Urokinase for Injection Revenue Market Share by Type (2019-2030)
    Figure 60. Asia Urokinase for Injection Sales Market Share by Application (2019-2030)
    Figure 61. Asia Urokinase for Injection Revenue Market Share by Application (2019-2030)
    Figure 62. Asia Urokinase for Injection Revenue Share by Region (2019-2030)
    Figure 63. Asia Urokinase for Injection Sales Share by Region (2019-2030)
    Figure 64. Japan Urokinase for Injection Revenue (2019-2030) & (US$ Million)
    Figure 65. South Korea Urokinase for Injection Revenue (2019-2030) & (US$ Million)
    Figure 66. China Taiwan Urokinase for Injection Revenue (2019-2030) & (US$ Million)
    Figure 67. Southeast Asia Urokinase for Injection Revenue (2019-2030) & (US$ Million)
    Figure 68. India Urokinase for Injection Revenue (2019-2030) & (US$ Million)
    Figure 69. Middle East, Africa and Latin America Urokinase for Injection Sales Market Share by Type (2019-2030)
    Figure 70. Middle East, Africa and Latin America Urokinase for Injection Revenue Market Share by Type (2019-2030)
    Figure 71. Middle East, Africa and Latin America Urokinase for Injection Sales Market Share by Application (2019-2030)
    Figure 72. Middle East, Africa and Latin America Urokinase for Injection Revenue Market Share by Application (2019-2030)
    Figure 73. Middle East, Africa and Latin America Urokinase for Injection Revenue Share by Country (2019-2030)
    Figure 74. Middle East, Africa and Latin America Urokinase for Injection Sales Share by Country (2019-2030)
    Figure 75. Brazil Urokinase for Injection Revenue (2019-2030) & (US$ Million)
    Figure 76. Mexico Urokinase for Injection Revenue (2019-2030) & (US$ Million)
    Figure 77. Turkey Urokinase for Injection Revenue (2019-2030) & (US$ Million)
    Figure 78. Israel Urokinase for Injection Revenue (2019-2030) & (US$ Million)
    Figure 79. GCC Countries Urokinase for Injection Revenue (2019-2030) & (US$ Million)
    Figure 80. Urokinase for Injection Value Chain
    Figure 81. Urokinase for Injection Production Process
    Figure 82. Channels of Distribution
    Figure 83. Distributors Profiles
    Figure 84. Bottom-up and Top-down Approaches for This Report
    Figure 85. Data Triangulation
    Figure 86. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

Global Urokinase Injection Market Research Report 2024
Global Urokinase Market Research Report 2025
Global Urokinase Lyophilized Powder Market Research Report 2024
Global Specific Plasminogen Activator Market Research Report 2024
Global Urokinase Powder Market Research Report 2024
Global uPA ELISA Kits Market Research Report 2024
Global Enterokinase Market Research Report 2025
Global Non specific Plasminogen Activator Market Research Report 2024
Global Thrombolytic Drug Market Insights Forecast to 2030
Global Crude Urokinase Market Research Report 2024
Global Serine Protease Market Insights Forecast to 2030
Global Protease for Animal Feed Market Research Report 2024
Thrombin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Feed Protease Market Research Report 2024
Thrombolysis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Intraoperative Ultrasound Market Insights Forecast to 2030
Streptokinase Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Industrial Proteases Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Recombinant Enterokinase Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Pegademase Bovine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions